Product correctly added to cart.

discount label
Loxoribine
View 3D

Targetmol logo

Loxoribine

CAS: 121288-39-9

Ref. TM-T15777

5mg
51.00 €
10mg
75.00 €
25mg
112.00 €
50mg
167.00 €
100mg
239.00 €
1ml*10 (DMSO)
52.00 €
Estimated delivery in United States, on Friday 10 May 2024

Product Information

Name:
Loxoribine
Synonyms:
  • RWJ 21757, 7-Allyl-8-oxoguanosine
  • 7,8-Dihydro-8-oxo-7-(2-propen-1-yl)guanosine
  • 7-Allyl-2-amino-9-beta-D-ribofuranosylpurine-6,8(1H,9H)-dione
  • 7-Allyl-8-oxoguanosine
  • 8-Oxo-7-Prop-2-En-1-Ylguanosine
  • Guanosine, 7,8-dihydro-8-oxo-7-(2-propen-1-yl)-
  • Guanosine, 7,8-dihydro-8-oxo-7-(2-propenyl)-
  • Loxoribina
  • Loxoribina [INN-Spanish]
  • Loxoribine [USAN:INN]
  • See more synonyms
  • Loxoribinum
  • Loxoribinum [INN-Latin]
  • Rwj 21757
  • Unii-9Cas0V66Oi
Description:

Loxoribine (RWJ 21757) is a guanosine analog. Loxoribine is an orally bioavailable and selective Toll-like receptor (TLR) 7 agonist. It has anti-viral and anti-tumor activities.Loxoribine is a potent new immunostimulant with a relatively broad spectrum of immunobiological activities.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
339.3
Formula:
C13H17N5O6
Purity:
99.73%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T15777 Loxoribine

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".